Thomas Mandel Clausen

Thomas Mandel Clausen

Associate Professor

  • CMP

    Blegdamsvej 3B

    2200 København N.

    Phone: +45 35 32 66 53

Member of:

  • VAR2CSA team


  1. 2017
  2. Published

    An oncofetal glycosaminoglycan modification provides therapeutic access to Cisplatin-resistant bladder cancer

    Seiler, R., Oo, H. Z., Tortora, D., Clausen, Thomas Mandel, Wang, C. K., Kumar, G., Ayres Pereira, M., Ørum-Madsen, M. S., Agerbæk, Mette Ørskov, Gustavsson, Tobias, Nordmaj, Mie Anemone, Rich, J. R., Lallous, N., Fazli, L., Lee, S., Douglas, J., Todenhöfer, T., Esfandnia, S., Battsogt, D., Babcook, J. S., Al Nakouzi, N., Crabb, S. J., Moskalev, I., Kiss, B., Davicioni, E., Thalmann, G. N., Rennie, P. S., Black, P. C., Salanti, Ali & Daugaard, M., 2017, In : European Urology Supplements. 72, 1, p. 142-150 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Burkitt lymphoma expresses oncofetal chondroitin sulfate without being a reservoir for placental malaria sequestration

    Agerbæk, Mette Ørskov, Bento Ayres Pereira, M. M., Clausen, Thomas Mandel, Pehrson, Caroline, Oo, H. Z., Spliid, Charlotte Bredo, Rich, J. R., Fung, V., Nkrumah, F., Neequaye, J., Biggar, R. J., Reynolds, S. J., Tosato, G., Pullarkat, S. T., Ayers, L. W., Theander, Thor Grundtvig, Daugaard, M., Bhatia, K., Nielsen, Morten Agertoug, Mbulaiteye, S. M. & Salanti, Ali, 2017, In : International Journal of Cancer. 140, 7, p. 1597–1608 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 35054027